SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunot…
Biotechnology
US, New York [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
SELLAS Life Sciences Group, Inc. has no acquisition track records yet.
M&A Deals · History
SELLAS Life Sciences Group, Inc. has no acquisition track records yet.